IngredientsLesser speargrass (Pogonatherum paniceum) is a perennial grass species traditionally recognized in various Asian cultures for its purported health-promoting properties. It belongs to the Poaceae family and is botanically designated Pogonatherum paniceum (Lam.) Hack., with the species epithet acknowledging the Swiss botanist Hans Hacker who formally described it. The genus name Pogonatherum derives from the Greek for "bearded spike," alluding to its characteristic inflorescence morphology.
The common name "Lesser speargrass" is used in supplement and nutritional-product contexts to distinguish this species from the broader "speargrass" complex, which includes the agriculturally more prominent Imperata cylindrica (cogon grass) and Heteropogon contortus (black speargrass). These are distinct species and should not be confused. P. paniceum is distributed in temperate, tropical, and subtropical regions in Asia, Africa, and Australia. It is widely distributed in the high mountains in Thailand, especially in rocky areas near water sources.
Pogonatherum paniceum is a highly drought- and salt-tolerant plant species that is typically used for ecological restoration and the conservation of soil and water in many countries.
In Thailand, the plant is commonly consumed as tea, prepared from dried aerial parts. The species is a perennial grass and preparations may also include water decoctions and ethanolic extracts for research purposes. In modern nutritional and supplement products, its inclusion is largely attributed to its rich content of bioactive compounds, including flavonoids, phenolic acids, and essential minerals. Standardized powdered extracts and encapsulated forms appear in commercial products, though formal standardization specifications have not been published in peer-reviewed literature.
Pogonatherum paniceum (Lamk) Hack is a perennial grass that has been used in traditional medicine in Southern China, India, and Southeast Asia. This herbaceous plant has been used in Thai traditional medicine to relieve numerous diseases such as edema, allergy, asthma, detoxification, hypertension, and hyperglycemia, and to heal wounds.
Historically, it has been used in folk medicine as a natural remedy for ailments such as fever, inflammation, and digestive disturbances.
In Thailand, P. paniceum is commonly consumed as tea. Dried aerial parts are the most frequently reported form used in folk preparation. Research voucher specimens of the plant used in laboratory studies have been deposited with the Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand, underscoring its recognized status within the official Thai traditional medicine framework.
In addition to its standalone uses, lesser speargrass has frequently been combined with other herbs to enhance its healing effects. When paired with plants like turmeric or ginger, it was believed to boost the body's immune response and accelerate recovery from illness. In some traditional Chinese and Ayurvedic practices, it formed part of complex herbal blends aimed at restoring balance and promoting overall well-being. These combinations were often tailored to address specific conditions, such as joint pain, fatigue, or respiratory complaints, leveraging the synergistic effects of multiple botanicals.
Note: The traditional use claims above derive from ethnobotanical and folk medicine accounts. They reflect historical and cultural practices and are not equivalent to clinically validated health claims.
Lesser speargrass's inclusion in nutritional products is largely attributed to its rich content of bioactive compounds, including flavonoids, phenolic acids, and essential minerals. Laboratory characterization of P. paniceum water extracts using high-performance liquid chromatography (HPLC) has identified specific polyphenolic constituents. Polyphenolic constituents detected in water extract include gallic acid, catechin, and quercetin.
Studies have explored the major polyphenolic components and the antioxidant and anti-inflammatory properties through TLR9 endosome activation of the P. paniceum water extract for potential health benefits.
The predominant classes of bioactive secondary metabolites characterized in P. paniceum are flavonoids and phenolic compounds. Active phytochemicals in herbal plants, predominantly flavonoids and phenolic compounds, have shown several pharmaceutical activities, including antioxidant, anticancer, antibacterial, cardioprotective, anti-inflammatory, immune modulation, and ultraviolet protective activities. Research published in the Journal of Integrative Medicine (2025) confirmed these compound classes in ethanolic extract of P. paniceum using advanced synchrotron-based analysis.
GDP-D-mannose pyrophosphorylase (GMPase) is the limiting enzyme in the synthesis of L-ascorbic acid (AsA), which plays a crucial role in the detoxification of reactive oxygen species (ROS). Understanding the molecular mechanisms underlying plant abiotic stress responses, especially to salinity and drought stresses, in species such as P. paniceum could be important to broader crop improvement efforts. While this enzymatic pathway pertains primarily to the plant's internal biochemistry, it implies a capacity for antioxidant compound biosynthesis within the organism.
Because P. paniceum belongs to the same family (Poaceae) and overlapping genera complexes as Imperata cylindrica, the secondary metabolite profiles of both are relevant for contextual understanding. To date, 72 chemical constituents have been isolated and identified from I. cylindrica; among these compounds, saponins, flavonoids, phenols, and glycosides are the major constituents. The main bioactive components are lignans and flavonoids, which may contribute either directly or indirectly to the biological effects. In P. paniceum, the primary confirmed bioactives are polyphenols (gallic acid, catechin, quercetin), while the broader flavonoid and phenolic acid classes remain under investigation.
The antioxidant properties of P. paniceum extracts are attributed to their polyphenolic composition. Data show that PPW extract has antioxidant and anti-inflammatory activities by facilitating mtDNA leakage and lowering the TLR9 expression and signaling activation. The quenching of reactive oxygen species (ROS) by phenolic compounds such as gallic acid, catechin, and quercetin is well-established for this compound class, and HPLC analysis has confirmed their presence in water extract of P. paniceum.
A mechanistic study published in Nutrition Research and Practice (2023) investigated the anti-inflammatory action of P. paniceum water extract at the cellular level. Mitochondrial DNA leakage leads to inflammatory responses via endosome activation. This study explored the major polyphenolic components and the antioxidant and anti-inflammatory properties through TLR9 endosome activation of P. paniceum water extract for potential health benefits. TLR9 (Toll-like receptor 9) is an innate immune receptor that recognizes unmethylated CpG DNA and plays a key role in inflammatory signaling cascades. The extract's capacity to attenuate TLR9-mediated inflammation provides a plausible cellular-level mechanism for the traditional anti-inflammatory use.
A 2025 study published in the Journal of Integrative Medicine extended current knowledge on the phytochemistry of P. paniceum ethanolic extract (PPE) and its antioxidant and cytoprotective effects, supporting the use of synchrotron radiation-based methods to determine the cytoprotective effects of natural products. PPE extract may be a candidate compound for new therapeutics and nutraceuticals that target the prevention of oxidative stress-associated diseases.
P. paniceum did not possess any toxicity (cytotoxic and mutagenic) but has the potential for anticancer activity against human colorectal cells by increasing apoptosis, which leads to the suppression of cell proliferation. Cell cycle arrest at G0–G1 phase in colorectal cancer cell lines (HCT116 and HT29) was documented in a 2023 in vitro study, representing a mechanism distinct from direct cytotoxicity.
Evidence level: Preliminary in vitro only.
Preliminary laboratory studies have demonstrated that extracts from the plant may possess antioxidant and anti-inflammatory properties, potentially contributing to the management of oxidative stress and inflammation-related conditions. The 2023 study by Thongboontho et al. (published in Nutrition Research and Practice) used RAW 264.7 macrophages stimulated with lipopolysaccharide (LPS) to model oxidative stress and inflammation. Macrophages were cultured and treated with different concentrations of PPW extract (10–800 μg/mL) for 24 and 48 h. The polyphenolic content of the water extract was quantified by HPLC, identifying gallic acid, catechin, and quercetin as major constituents. Antioxidant activity was confirmed in cell culture. No human clinical trials investigating antioxidant endpoints of P. paniceum have been published to date.
Evidence level: Preliminary in vitro (cell culture) only.
The Thongboontho et al. (2023) study in Nutrition Research and Practice represents the primary published mechanistic investigation of anti-inflammatory activity in P. paniceum. The polyphenolic constituents of P. paniceum (PPW) were investigated by high-performance liquid chromatography, after which their antioxidant activities were assessed. RAW 264.7 macrophages were stimulated with lipopolysaccharide, resulting in mitochondrial damage. The extract attenuated inflammatory signaling via the TLR9 pathway. This is a single in vitro study in a macrophage cell-line model; findings have not been replicated in animal models or human studies for this specific species.
Evidence level: Preliminary in vitro (cancer cell lines) only. No clinical trials available.
A 2023 study published in World Journal of Oncology (Praphasawat et al., DOI: 10.14740/wjon1602) examined the antiproliferative and antimutagenic properties of P. paniceum water extract in human colorectal cancer cell lines. To investigate P. paniceum's anticancer ability, HCT116 and HT29 cell lines were treated with a water extract containing P. paniceum, and then the cell viability was examined using the trypan blue exclusion method which were compared to HEK293 (non-cancerous cells). The anticancer effects were investigated by MTS and colony formation assay. P. paniceum did not possess any toxicity (cytotoxic and mutagenic) but has the potential for anticancer activity against human colorectal cells by increasing apoptosis, which leads to the suppression of cell proliferation. The study also reported G0–G1 cell cycle arrest in treated cancer cell lines. These findings are limited to in vitro conditions and cannot be extrapolated to efficacy in humans without further animal and clinical investigation.
Evidence level: In vitro (cell-based assay), no clinical evidence.
A 2025 study published in the Journal of Integrative Medicine (Dunkhunthod et al., 2025; 23(2): 182–194) evaluated cytoprotective effects of P. paniceum ethanolic extract using synchrotron radiation-based FTIR microspectroscopy. This study extended current knowledge on the phytochemistry of PPE and its antioxidant and cytoprotective effects, supported the use of SR-FTIR microspectroscopy to determine the cytoprotective effects of natural products, and concluded that PPE extract may be a candidate compound for new therapeutics and nutraceuticals that target the prevention of oxidative stress-associated diseases. Evidence remains in vitro.
A further study referenced in the Revista Brasileira de Farmacognosia (2024) examined the photoprotective effect of P. paniceum extract against UVB-induced skin aging in HaCaT keratinocytes (a human keratinocyte cell line), also finding that the extract attenuated UVB-induced reactive oxygen species generation at specific concentrations. This study was also in vitro only.
Evidence level: Traditional use; in vitro cellular support only for P. paniceum specifically.
Pogonatherum paniceum (Lam.) Hack. plays an important role in detoxification as recognized in traditional practice. Scientific validation of lesser speargrass's health benefits is an emerging field. No hepatoprotective clinical or animal studies specific to P. paniceum were identified in the available peer-reviewed literature. (Hepatoprotective data for the related species Imperata cylindrica exist in animal models but cannot be attributed directly to P. paniceum.)
Evidence level: Traditional use only; no clinical studies found for these indications.
P. paniceum has been used in Thai traditional medicine to relieve numerous diseases such as edema, allergy, asthma, detoxification, hypertension, and hyperglycemia, and to heal wounds. None of these traditional applications have been investigated in controlled clinical or even animal studies specific to P. paniceum as of the available published literature. These remain ethnobotanical observations without experimental verification.
No standardized dosage for P. paniceum has been established or endorsed by any governmental regulatory body, pharmacopeia, or systematic clinical review. The following are forms and concentration ranges described or employed in published research:
Scientific validation of lesser speargrass's health benefits is an emerging field, and no human clinical dose-finding or pharmacokinetic studies for P. paniceum have been published. Any dosage recommendations appearing on commercial supplement labels are not supported by peer-reviewed clinical data.
P. paniceum did not possess any toxicity (cytotoxic and mutagenic) in the 2023 in vitro colorectal cancer study, where non-cancerous HEK293 cells were used as a comparator to assess selective antiproliferative activity. However, this finding applies only to the in vitro conditions of that study and cannot be generalized to oral human safety.
No studies have explored its bioactive compounds and their biological effects, and its underlying mechanism of action remains poorly understood. This statement — from a 2023 peer-reviewed study in Nutrition Research and Practice — highlights the significant gaps in the safety evidence base for P. paniceum. Formal oral toxicity studies (acute, sub-chronic, chronic) specific to P. paniceum have not been published.
As a member of the Poaceae (grass) family, P. paniceum may theoretically share allergenic proteins with other grasses; cross-reactivity with other grass pollens or proteins is a plausible concern for individuals with known grass allergies. This has not been specifically studied for P. paniceum.
As of the available literature, no formal safety review, monograph, or approved indication for P. paniceum has been published by the WHO, European Medicines Agency (EMA), U.S. FDA, or equivalent pharmacopoeial body. The German Commission E, ESCOP, and WHO monograph series do not include a specific monograph for Pogonatherum paniceum.
Although toxicology data from I. cylindrica cannot be applied directly to P. paniceum, they are informative for the broader botanical context. A preclinical study in BMC Complementary Medicine and Therapies (2020) assessed acute and sub-chronic oral toxicity of methanol root extract of Imperata cylindrica in rats: from the results of the acute oral toxicity assay, ICR was found to be non-toxic at the dose of 5000 mg/kg b.w. During the period of sub-chronic toxicity test, observation of signs, behavior and health status of the animals showed no abnormality in the groups of animals treated with ICR as compared to the controls. Significant variation of the relative body weights of heart and kidney were observed at a dose of 1000 mg/kg b.w. Histological examinations performed on kidney and liver showed a normal kidney architecture and liver also presented a normal hepatic architecture with slight degeneration at a dose 1000 mg/kg b.w. ICR is safe for acute oral administration; however, for long-term oral administration, safety measures should be taken. Oral sub-chronic exposure of ICR at lower doses are recommended while higher doses around 1000 mg/kg b.w. should be discouraged. These findings are from an animal study of a different species and are presented here solely for contextual orientation, not as applicable safety data for P. paniceum.
The body of evidence for lesser speargrass (Pogonatherum paniceum) as a dietary supplement ingredient is sparse and preliminary. Scientific validation of lesser speargrass's health benefits is an emerging field. All published pharmacological studies are in vitro (cell culture) investigations. No controlled animal pharmacology studies, no human pharmacokinetic studies, and no randomized clinical trials for any health indication have been published for this species. The traditional use record — principally from Thailand, Southern China, India, and Southeast Asia — provides ethnobotanical context but does not constitute clinical evidence. The mechanistic hypotheses generated by cell-culture research (TLR9 anti-inflammatory pathway, apoptosis induction in cancer lines, ROS scavenging) are biologically plausible but require validation at the animal and human levels before any health claim can be substantiated.
Health conditions that Lesser speargrass may help support.
Body systems that Lesser speargrass may help support.
Go back